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Summary {#efs25254-sec-0001}
=======

In accordance with Article 6 of Regulation (EC) No 396/2005, the Task Force Abamectin submitted an application to the competent national authority in Spain (evaluating Member State (EMS)) to modify the existing maximum residue level (MRL) for the active substance abamectin in citrus fruits. The EMS drafted an evaluation report in accordance with Article 8 of Regulation (EC) No 396/2005, which was submitted to the European Commission and forwarded to the European Food Safety Authority (EFSA). EFSA identified data gaps and points that needed further clarifications, which were addressed by the EMS in a revised evaluation report. To accommodate for the intended use of abamectin, the EMS proposed to raise the existing MRL to 0.04 mg/kg.

EFSA based its assessment on the revised evaluation report submitted by the EMS, the draft assessment report (DAR) prepared under Directive 91/414/EEC, the Commission review report and its addendum, the conclusions on the peer review of the pesticide risk assessment of the active substance abamectin, the Joint Meeting on Pesticide Residues (JMPR) evaluation reports as well as the conclusions from previous EFSA opinions on abamectin.

The metabolism of abamectin was investigated in primary crops belonging to the group of fruit crops, leafy crops and pulses/oilseeds following foliar applications and in rotational crops in root/tuber crops, leafy crops and cereals (small grain) following soil application during the European Union (EU) pesticides peer review. Studies investigating the effect of processing on the nature of abamectin showed limited degradation under standard processing conditions.

Based on the metabolic pattern identified in metabolism studies, hydrolysis studies and the toxicological significance of metabolites, the capabilities of the analytical methods, the residue definition for enforcement and risk assessment was proposed as 'abamectin (sum of avermectin B~1a~, avermectin B~1b~ and delta‐8,9‐isomer of avermectin B~1a~, expressed as avermectin B~1a~)'. The residue definition is applicable to primary crops, including the crops under assessment, rotational crops and processed products.

The available residue trials were sufficient to derive a MRL proposal of 0.04 mg/kg for citrus fruits. The additional validation data in high acid content matrices assessed under the current application demonstrated that the enforcement methods are suitable to control residues of abamectin in citrus fruits. The methods determine residues at or above the limit of quantification (LOQ) of 0.002 mg/kg (combined LOQ of 0.006 mg/kg). The new data provided addressed the data gap identified for high acid content matrices in the MRL review.

As citrus dried pulp may be used as a feed product, a potential carry‐over of residues into food of animal origin was assessed. The residue levels in citrus by‐products resulting from the intended use did not require a modification of the existing MRLs for animal products.

The toxicological profile of abamectin was assessed in the framework of the EU pesticides peer review and the data were sufficient to derive an acceptable daily intake (ADI) of 0.0025 mg/kg body weight (bw) per day and an acute reference dose (ARfD) of 0.005 mg/kg bw. The metabolite included in the residue definition was considered to be of the same toxicity as the parent active substance.

The consumer risk assessment was performed with revision 2 of the EFSA Pesticide Residues Intake Model (PRIMo). The chronic consumer risk assessment performed in the framework of previous MRL assessments was updated, including the supervised trials median residue (STMR) derived for citrus fruits. The short‐term exposure assessment was performed only with regard to the commodities under consideration.

Based on the available information, EFSA concluded that the proposed use of abamectin on citrus fruits will not result in a consumer exposure exceeding the toxicological reference values and therefore is unlikely to pose a risk to consumers\' health.

EFSA proposes to amend the existing MRL as reported in the summary table below. Code[a](#efs25254-note-1005){ref-type="fn"}CommodityExisting EU MRL (mg/kg)Proposed EU MRL (mg/kg)Comment/justification**Enforcement residue definition:** Abamectin (sum of avermectin B~1a~, avermectin B~1b~ and delta‐8,9‐isomer of avermectin B~1a~, expressed as avermectin B~1a~)[F](#efs25254-note-1006){ref-type="fn"} ^,^ [R](#efs25254-note-1007){ref-type="fn"}0110000Citrus fruits0.0150.04SEU use supported by extrapolation from residue data on oranges and mandarins. Risk for consumers unlikely[^1][^2][^3][^4]

In the framework of the MRL review under Article 12 of Regulation (EC) No 396/2005, a data gap was identified (validation of the analytical methods for crop matrices with high acid). Since the information submitted within the current application was considered sufficient to address the open questions, the footnote on missing confirmatory data for commodities classified as high‐acid content commodities can be deleted in the MRL legislation.

Background {#efs25254-sec-0003}
==========

Regulation (EC) No 396/2005[1](#efs25254-note-1008){ref-type="fn"} (hereinafter referred to as 'the MRL regulation') establishes the rules governing the setting of pesticide maximum residue levels (MRLs) at European Union (EU) level. Article 6 of the MRL regulation lays down that any party having a legitimate interest or requesting an authorisation for the use of a plant protection product in accordance with Directive 91/414/EEC[2](#efs25254-note-1009){ref-type="fn"}, repealed by Regulation (EC) No 1107/2009[3](#efs25254-note-1010){ref-type="fn"}, shall submit an application to a Member State to modify a MRL in accordance with the provisions of Article 7 of the MRL regulation.

The applicant 'Task Force Abamectin' submitted an application to the competent national authority in Spain, hereafter referred to as the evaluating Member State (EMS), to modify the existing MRL for the active substance abamectin in citrus fruits. This application was notified to the European Commission and the European Food Safety Authority (EFSA) and was subsequently evaluated by the EMS in accordance with Article 8 of the MRL regulation. The EMS summarised the data provided by the applicant in an evaluation report which was submitted to the European Commission and forwarded to EFSA. The application was included in the EFSA Register of Questions with the reference number EFSA‐Q‐2015‐00809 and the following subject:

*Abamectin -- Setting of new MRLs in citrus*.

Spain proposed to raise the existing MRL of abamectin in citrus fruits from the value of 0.015 to 0.04 mg/kg. EFSA assessed the application and the evaluation report as required by Article 10 of the MRL regulation. EFSA identified data gaps and points that needed further clarifications, which were addressed by the EMS in a revised evaluation report. The last revision of the evaluation report (Spain, [2018](#efs25254-bib-0028){ref-type="ref"}) replaced the previously submitted versions.

Terms of Reference {#efs25254-sec-0004}
==================

In accordance with Article 10 of Regulation (EC) No 396/2005, EFSA shall assess the application and the evaluation report and give a reasoned opinion on the risks to the consumer and where relevant to animals associated with the setting of the requested MRLs. The opinion shall include: an assessment of whether the analytical method for routine monitoring proposed in the application is appropriate for the intended control purposes;the anticipated limit of quantification (LOQ) for the pesticide/product combination;an assessment of the risks of the acceptable daily intake and acute reference dose being exceeded as a result of the modification of the MRL;the contribution to the intake due to the residues in the product for which the MRLs was requested;any other element relevant to the risk assessment.

In accordance with Article 11 of the MRL regulation, EFSA shall give its reasoned opinion as soon as possible and at the latest within three months from the date of receipt of the application.

The revised evaluation report submitted by the EMS (Spain, [2018](#efs25254-bib-0028){ref-type="ref"}) and the exposure calculations using the EFSA Pesticide Residues Intake Model (PRIMo) are considered as supporting documents to this reasoned opinion and thus are made publicly available.

The active substance and its use pattern {#efs25254-sec-0005}
========================================

The detailed description of the intended use of abamectin which is the basis for the current MRL application is reported in Appendix [A](#efs25254-sec-1002){ref-type="sec"}.

Abamectin is the ISO common name for the mixture of avermectin B~1a~ (≥ 80%) and avermectin B~1b~ (≤ 20%).

The IUPAC names for the two components of abamectin are:

Avermectin B1a:

(2a*E*,4*E*,8*E*)‐(5′*S*,6*S*,6′*R*,7*S*,11*R*,13*S*,15*S*,17a*R*,20*R*,20a*R*,20b*S*)‐6′‐\[(*S*)‐*sec*‐butyl\]‐5′,6,6′,7,10,11,14,15,17a,20,20a,20b‐dodecahydro‐20,20b‐dihydroxy‐5′,6,8,19‐tetramethyl‐17 oxospiro\[11,15‐methano‐2*H*,13*H*,17*H*‐furo\[4,3,2‐*pq*\]\[2,6\]benzodioxacyclooctadecin‐13,2′‐\[2*H*\]pyran\]‐7‐yl 2,6‐dideoxy‐4‐*O*‐(2,6‐dideoxy‐3‐*O*‐methyl‐α‐[l]{.smallcaps}‐arabino‐hexopyranosyl)‐3‐*O*‐methyl‐α‐[l]{.smallcaps}‐arabino‐hexopyranoside

Avermectin B1b:

(2a*E*,4*E*,8*E*)‐(5′*S*,6*S*,6′*R*,7*S*,11*R*,13*S*,15*S*,17a*R*,20*R*,20a*R*,20b*S*)‐5′,6,6′,7,10,11,14,15,17a,20,20a,20bdodecahydro‐20,20b‐dihydroxy‐6′‐isopropyl‐5′,6,8,19‐tetramethyl‐17‐oxospiro\[11,15‐methano‐2*H*,13*H*,17*H*‐furo\[4,3,2‐*pq*\]\[2,6\]benzodioxacyclooctadecin 13,2′‐\[2*H*\]pyran\]‐7‐yl 2,6‐dideoxy‐4‐*O*(2,6‐dideoxy‐3‐*O*‐methyl‐α‐L‐arabino‐hexopyranosyl)‐3‐*O*‐methyl‐α‐[l]{.smallcaps}‐arabino‐hexopyranoside

The chemical structures of the active substance, its main components and major metabolite are reported in Appendix [D](#efs25254-sec-1005){ref-type="sec"}.

Abamectin was approved on 1 May 2009 for the use as insecticide and acaricide[4](#efs25254-note-1011){ref-type="fn"} and on 3 April 2017 the use was extended to nematicide.[5](#efs25254-note-1012){ref-type="fn"} The EU MRLs for abamectin are established in Annexes II of Regulation (EC) No 396/2005. The review of existing MRLs according to Article 12 of Regulation (EC) No 396/2005 (MRL review) has been performed (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"}) and the proposed modifications have been implemented in the EU MRL legislation.[6](#efs25254-note-1013){ref-type="fn"} After completion of the MRL review, EFSA has issued two reasoned opinions on the modification of MRLs for abamectin (EFSA, [2015](#efs25254-bib-0005){ref-type="ref"}, [2017](#efs25254-bib-0007){ref-type="ref"}). The MRL proposals on from these reasoned opinions have been implemented in an MRL regulation[7](#efs25254-note-1014){ref-type="fn"} or were voted at the SCoPAFF meeting (the regulation implementing the MRL proposal on bananas has not yet been published). Abamectin is authorised for use in veterinary medicine; the MRLs set in Regulation (EU) No 37/2010[8](#efs25254-note-1015){ref-type="fn"} have been taken over in the EU pesticide legislation.

Assessment {#efs25254-sec-0006}
==========

EFSA has based its assessment on the revised evaluation report submitted by the EMS (Spain, [2018](#efs25254-bib-0028){ref-type="ref"}), the DAR and its addendum prepared under Directive 91/414/EEC (Netherlands, [2005](#efs25254-bib-0024){ref-type="ref"}, [2008](#efs25254-bib-0025){ref-type="ref"}), the European Commission review report on abamectin and its addendum (European Commission, [2008](#efs25254-bib-0501){ref-type="ref"}, [2017a](#efs25254-bib-0018){ref-type="ref"}), the conclusion on the peer review of the pesticide risk assessment of the active substance abamectin (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"}, [2016](#efs25254-bib-0006){ref-type="ref"}), the JMPR Evaluation reports (FAO, [1992](#efs25254-bib-0020){ref-type="ref"}, [1997](#efs25254-bib-0021){ref-type="ref"}, [2015](#efs25254-bib-0022){ref-type="ref"}) as well as the conclusions from previous EFSA opinions on abamectin (EFSA, [2010](#efs25254-bib-0003){ref-type="ref"}, [2014](#efs25254-bib-0004){ref-type="ref"}, [2015](#efs25254-bib-0005){ref-type="ref"}, [2017](#efs25254-bib-0007){ref-type="ref"}).

For this application, the data requirements established in Regulation (EU) No 544/2011[9](#efs25254-note-1016){ref-type="fn"} and the guidance documents applicable at the date of submission of the application to the EMS are applicable (European Commission, [1997a](#efs25254-bib-0008){ref-type="ref"} [b](#efs25254-bib-0009){ref-type="ref"} [c](#efs25254-bib-0010){ref-type="ref"} [d](#efs25254-bib-0011){ref-type="ref"} [e](#efs25254-bib-0012){ref-type="ref"} [f](#efs25254-bib-0013){ref-type="ref"} [g](#efs25254-bib-0014){ref-type="ref"} [2000](#efs25254-bib-0015){ref-type="ref"}, [2010a](#efs25254-bib-0016){ref-type="ref"} [b](#efs25254-bib-0017){ref-type="ref"}, [2017b](#efs25254-bib-0019){ref-type="ref"}; OECD, [2011](#efs25254-bib-0026){ref-type="ref"}). The assessment is performed in accordance with the legal provisions of the Uniform Principles for the Evaluation and the Authorisation of Plant Protection Products adopted by Commission Regulation (EU) No 546/2011[10](#efs25254-note-1017){ref-type="fn"}.

A selected list of end points of the studies assessed by EFSA in the framework of the MRL review, including the end points of studies submitted in support of previous and current MRL applications, are presented in Appendix [B](#efs25254-sec-1003){ref-type="sec"}.

1. Residues in plants {#efs25254-sec-0007}
=====================

1.1. Nature of residues and methods of analysis in plants {#efs25254-sec-0008}
---------------------------------------------------------

### 1.1.1. Nature of residues in primary crops {#efs25254-sec-0009}

The metabolism of abamectin following foliar applications was investigated in primary crops belonging to the fruit crops, leafy crops and pulses/oilseeds groups using avermectin B~1a~ in the framework of the EU pesticides peer review and the MRL review (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"}, [2014](#efs25254-bib-0004){ref-type="ref"}). Avermectin B~1a~ was largely metabolised but represented still the predominant compound in almost all plant parts (4--23% total radioactive residue (TRR) at preharvest interval (PHI) of 8 days). The photolysis product delta‐8,9‐isomer of avermectin B~1a~ (also referred to as (*Z*)‐8,9‐isomer) was found in concentrations not exceeding 10% TRR, but considered of the same toxicity as B~1a~. Details of the metabolism studies are presented in Appendix [B](#efs25254-sec-1003){ref-type="sec"}.

### 1.1.2. Nature of residues in rotational crops {#efs25254-sec-0010}

Abamectin is proposed for use on permanent crops and investigations of residues in rotational crops are not required. Although accumulation is not expected (DT~90~ \< 1 day), confined rotational crop studies were assessed in the EU pesticides peer review (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"}). Details of the studies are presented in Appendix [B](#efs25254-sec-1003){ref-type="sec"}.

### 1.1.3. Nature of residues in processed commodities {#efs25254-sec-0011}

The effect of processing on the nature of abamectin was investigated using avermectin B~1a~ in the framework of the EU pesticides peer review (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"}). Some degradation of abamectin was observed. The major degradation product was considered of the same toxicity as the parent. Therefore, no reduction factor related to processing should be used in risk assessment. The MRL review confirmed the conclusion of the EU pesticides peer review that the residue definition for enforcement and risk assessment proposed for plant commodities is applicable to processed commodities.

### 1.1.4. Methods of analysis in plants {#efs25254-sec-0012}

Analytical methods using liquid chromatography with tandem mass spectrometry (LC--MS/MS) were validated for one ion transition in high water, high acid and high oil content commodities. According to the previous EFSA reasoned opinions, confirmatory methods with an additional ion transition and independent laboratory validation (ILV) are missing for high acid and high oil content commodities (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"}, [2017](#efs25254-bib-0007){ref-type="ref"}). Further validation data for the LC--MS/MS method in high acid content matrices (strawberry) and the ILV were assessed in the framework of the current MRL application (Spain, [2018](#efs25254-bib-0028){ref-type="ref"}). The methods are able to quantify avermectin B~1a~, avermectin B~1b~ and the delta‐8,9‐isomer of B~1a~ at or above the LOQ of 0.002 mg/kg for each analyte (combined LOQ of 0.006 mg/kg). The new data provided addressed the data gap identified for high acid content matrices in the MRL review.

### 1.1.5. Stability of residues in plants {#efs25254-sec-0013}

The storage stability of avermectin B~1a~, avermectin B~1b~ and the delta‐8,9‐isomer of avermectin B~1a~ in plants stored under deep freeze conditions was investigated in the framework of the EU pesticides peer review (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"}). It was demonstrated that in the group to which the crops assessed in this application belong, residues were stable during frozen storage for up to 14 months. Additional storage stability data provided in the current MRL application showed stability in orange peel and pulp for at least 12 months under deep‐freeze conditions (Spain, [2018](#efs25254-bib-0028){ref-type="ref"}).

### 1.1.6. Proposed residue definitions {#efs25254-sec-0014}

Based on the metabolic pattern identified in metabolism studies, the results of hydrolysis studies, the toxicological significance of metabolites, the capabilities of analytical methods, the residue definition for enforcement and risk assessment proposed in the EU pesticides peer review in 2008 and confirmed during the MRL review is:

'abamectin (sum of avermectin B~1a~, avermectin B~1b~ and delta‐8,9‐isomer of avermectin B~1a~, expressed as avermectin B~1a~)'

The same residue definition is currently set in Regulation (EC) No 396/2005.

The residue definition applies to primary crops, rotational crops and processed products.

Taking into account the proposed use assessed in this application, EFSA concluded that this residue definition is appropriate for the crop under assessment.

EFSA emphasised that the above studies do not investigate the possible impact of plant metabolism on the isomer ratio of abamectin and further investigation on this matter would in principle be required. Since guidance on the consideration of isomer ratios in the consumer risk assessment is not yet implemented, EFSA recommends that this issue is reconsidered after implementation.

1.2. Magnitude of residues in plants {#efs25254-sec-0015}
------------------------------------

### 1.2.1. Magnitude of residues in primary crops {#efs25254-sec-0016}

Residue trials conducted with abamectin on oranges and mandarins over two seasons in southern Europe were submitted. Although few single applications slightly exceeded the acceptable tolerance of +25% in rate, the trials were considered acceptable since the deviation was no more than 32%. Extrapolation from oranges and mandarins is possible (European Commission, [2017b](#efs25254-bib-0019){ref-type="ref"}). The residue data supported a MRL proposal for the group of citrus fruits.

According to the EMS, the samples were analysed for avermectin B~1a~, avermectin B~1b~ and delta‐8,9‐isomer of avermectin B~1a~ with a sufficiently validated analytical method and were stored for up to 12 months under conditions for which integrity was demonstrated.

### 1.2.2. Magnitude of residues in rotational crops {#efs25254-sec-0017}

Not required (intended use is on permanent crops).

### 1.2.3. Magnitude of residues in processed commodities {#efs25254-sec-0018}

Specific studies to assess the magnitude of abamectin residues in processed commodities are not required, because the residue concentration in the raw agricultural commodity were low (\< 0.1 mg/kg) (European Commission, [1997d](#efs25254-bib-0011){ref-type="ref"}). The distribution of residues between peel and pulp was determined and a tentative peeling factor was derived from the two trials with quantifiable residues in the whole fruit.

### 1.2.4. Proposed MRLs {#efs25254-sec-0019}

The available data were considered sufficient to derive a MRL proposal as well as risk assessment values for citrus fruits (see Appendix [B.1.2.1](#efs25254-sec-0032){ref-type="sec"}). In Section [3](#efs25254-sec-0021){ref-type="sec"}, EFSA assessed whether residues on these crops resulting from the intended use are likely to pose a consumer health risk.

2. Residues in livestock {#efs25254-sec-0020}
========================

Citrus dried pulp may be used for feed purposes. Livestock dietary burdens were calculated for different groups of livestock according to OECD guidance (OECD, [2013](#efs25254-bib-0027){ref-type="ref"}). The input values are summarised in Appendix [D.1](#efs25254-sec-0043){ref-type="sec"}. The results of the calculations are presented in Appendix [B.3](#efs25254-sec-0040){ref-type="sec"}.

The dietary burdens derived did not exceed the trigger value of 0.1 mg/kg dry matter (DM) for all relevant groups of livestock. The existing MRLs in edible tissues of bovine and ovine are the legal limits resulting from the use in veterinary medicine. The residue levels in citrus by‐products resulting from the intended use do not require a modification of the existing MRLs for animal products.

3. Consumer risk assessment {#efs25254-sec-0021}
===========================

EFSA performed a dietary risk assessment using revision 2 of the EFSA PRIMo (EFSA, [2007](#efs25254-bib-0001){ref-type="ref"}). This exposure assessment model contains food consumption data for different sub‐groups of the EU population and allows the acute and chronic exposure assessment to be performed in accordance with the internationally agreed methodology for pesticide residues (FAO, [2016](#efs25254-bib-0023){ref-type="ref"}). The complete list of input values can be found in Appendix [D.2](#efs25254-sec-0044){ref-type="sec"}.

The toxicological reference values for abamectin used in the risk assessment (i.e. acceptable daily intake (ADI) and acute reference dose (ARfD) values) were derived in the framework of the EU pesticides peer review (European Commission, [2008](#efs25254-bib-0501){ref-type="ref"}). The metabolite included in the residue definition was considered to be of the same toxicity as the parent active substance.

3.1. Short‐term (acute) dietary risk assessment {#efs25254-sec-0022}
-----------------------------------------------

The short‐term exposure assessment was performed for the commodities assessed in this application in accordance with the internationally agreed methodology (FAO, [2016](#efs25254-bib-0023){ref-type="ref"}). The calculations were based on the highest reside (HR) in the edible portion of citrus fruits (pulp, excluding peel) derived from supervised field trials. As worst case, the EMS used the HR derived for the whole fruit in the risk assessment (Spain, [2018](#efs25254-bib-0028){ref-type="ref"}). The short‐term exposure did not exceed the ARfD for the crops assessed in this MRL application (see Appendix [B.4](#efs25254-sec-0041){ref-type="sec"}).

3.2. Long‐term (chronic) dietary risk assessment {#efs25254-sec-0023}
------------------------------------------------

The chronic consumer risk assessment performed in the framework of the MRL review was already revised twice to include median residue levels (STMRs) assessed in EFSA reasoned opinions issued after the MRL review (EFSA, [2015](#efs25254-bib-0005){ref-type="ref"}, [2017](#efs25254-bib-0007){ref-type="ref"}). The calculation was revised further with the STMR derived for peeled citrus fruits.

The estimated long‐term dietary intake was in the range of 2--10% of the ADI. The contribution of residues expected in the commodities assessed in this application to the overall long‐term exposure is presented in more detail in Appendix [B.4](#efs25254-sec-0041){ref-type="sec"}.

EFSA concluded that the long‐term intake of residues of abamectin resulting from the existing and the intended uses is unlikely to present a risk to consumer health.

Conclusions and recommendations {#efs25254-sec-0024}
===============================

The data submitted in support of this MRL application were found to be sufficient to derive MRL proposals for citrus fruits. Adequate analytical methods for enforcement are available to control the residues of abamectin in the commodity under consideration. Based on the available information, EFSA concluded that the short‐term and long‐term intake of residues resulting from the use of abamectin according to the reported agricultural practice is unlikely to present a risk to consumer health.

EFSA emphasised that the above assessment did not consider the possible impact of plant metabolism on the isomer ratio of the active substance and further investigation on this matter would in principle be required. Since guidance on how to address the dietary risk assessment of isomer mixture is not yet implemented, EFSA recommended that the issue is reconsider after implementation. The lack of information on the isomer composition in plants is a source of uncertainty in the consumer risk assessment, which was estimated to be of limited or no material impact considering that the wide margin of exposure is expected to offset the overall uncertainty within the risk assessment.

The MRL recommendations were summarised in Appendix [B.4](#efs25254-sec-0041){ref-type="sec"}.

Abbreviations {#efs25254-sec-0025}
=============

a.s.active substanceADIacceptable daily intakeARapplied radioactivityARfDacute reference doseBBCHgrowth stages of mono‐ and dicotyledonous plantsbwbody weightCFconversion factor for enforcement to risk assessment residue definitionCVcoefficient of variation (relative standard deviation)DALAdays after last applicationDARdraft assessment reportDATdays after treatmentDMdry matterDT~90~period required for 90% dissipation (define method of estimation)ECemulsifiable ConcentrateEMSevaluating Member StateFAOFood and Agriculture Organization of the United NationsGAPGood Agricultural PracticeHPLC‐MS/MShigh‐performance liquid chromatography with tandem mass spectrometryHRhighest residueIEDIinternational estimated daily intakeIESTIinternational estimated short‐term intakeILVindependent laboratory validationISOInternational Organisation for StandardisationIUPACInternational Union of Pure and Applied ChemistryJMPRJoint FAO/WHO Meeting on Pesticide ResiduesLCliquid chromatographyLODlimit of detectionLOQlimit of quantificationMRLmaximum residue levelMS/MStandem mass spectrometry detectorMWmolecular weightNEUnorthern EuropeOECDOrganisation for Economic Co‐operation and DevelopmentPBIplant‐back intervalPFprocessing factorPHIpreharvest intervalPRIMo(EFSA) Pesticide Residues Intake ModelRArisk assessmentRACraw agricultural commodityRDresidue definitionSANCODirectorate‐General for Health and ConsumersSEUsouthern EuropeSMILESsimplified molecular‐input line‐entry systemSTMRsupervised trials median residueTRRtotal radioactive residueWHOWorld Health Organization

Appendix A -- Summary of intended GAP triggering the amendment of existing EU MRLs {#efs25254-sec-1002}
==================================================================================

 {#efs25254-sec-0026}

Crop and/or situationNEU, SEU, MS or countryF G or I[a](#efs25254-note-1019){ref-type="fn"}Pests or group of pests controlledPreparationApplicationApplication rate per treatmentPHI (days)[d](#efs25254-note-1022){ref-type="fn"}RemarksType[b](#efs25254-note-1020){ref-type="fn"}Conc. a.s.Method kindRange of growth stages and season[c](#efs25254-note-1021){ref-type="fn"}Number min--maxInterval between application (min)g a.s./hL min--maxWater L/ha min--maxRateUnitCitrus fruitsSEUF*Phyllocnistis citrella, Tetranychus urticae, Panonychus citri, Aceria sheldoni*EC18 g/LTractor mounted sprayer (atomisers)BBCH 31--32 BBCH 71--741--37 days0.54--0.721,000--2,0005.4--14.4g/ha10[^5][^6][^7][^8][^9]

Appendix B -- List of end points {#efs25254-sec-1003}
================================

B.1.. Residues in plants {#efs25254-sec-0027}
------------------------

### B.1.1.. Nature of residues and methods of analysis in plants {#efs25254-sec-0028}

#### B.1.1.1.. Metabolism studies, methods of analysis and residue definitions in plants {#efs25254-sec-0029}

Primary crops (available studies)Crop groupsCrop(s)Application(s)SamplingComment/sourceFruit cropsCitrus fruitsOnto fruit, 1 × 4 μg/fruit and 1 × 40 μg/fruit1, 2, 4, 8, 12 weeks post application^14^C‐avermectin B~1a~ (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"})TomatoesFoliar (F, G), 5 × 0.026 kg/ha0, 3, 7, 14, 28 DALA^14^C‐avermectin B~1a~ (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"})Foliar (G), 3 × 0.28 kg/haFoliar (F), 3 × 0.25 kg/haLeafy cropsCeleryFoliar (F) to immature plants, 4 × 0.017 kg/ha0, 14 DALA^14^C‐avermectin B~1a~ (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"})Foliar (F) to immature plants, 4 × 0.011 kg/ha and 4 × 0.110 kg/ha0, 7, 14, 29, 43 DALA^3^H‐avermectin B~1a~ (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"})Foliar (F) to mature plants, 10 × 0.017 kg/ha0, 7 DALA^14^C‐avermectin B~1a~ (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"})Foliar (F) to mature plants, 10 × 0.011 kg/ha and 10 × 0.110 kg/ha0, 1, 3, 7, 15, 22 DALA^3^H‐avermectin B~1a~ (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"})Pulses/oilseedsCottonOnto leaf, 1 × 200 μL/leaf0, 1, 2, 4, 8 DAT^14^C‐ avermectin B^1a^ (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"})Foliar (F), 2 × 0.02 kg/ha60 DALA^14^C‐ avermectin B~1a~ (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"})Foliar (F), 3 × 0.022 and 3 × 0.22 kg/ha21 DALA^14^C‐ avermectin B~1a~ (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"})Rotational crops (available studies)Crop groupsCrop(s)Application(s)PBI (DAT)Comment/sourceRoot/tuber cropsCarrotsSoil application, 3 × 0.029 and 12 × 0.034 kg/ha14--31, 120--123, 365^14^C‐avermectin B~1a~ (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"}) Studies provided although not triggered (DT~90~ avermectin B~1a~ \< 1 day)TurnipsLeafy cropsLettuceCereal (small grain) otherSorghumProcessed commodities (hydrolysis study)ConditionsStable?Comment/sourcePasteurisation (20 min, 90°C, pH 4)YesStudy performed with ^14^C‐avermectin B~1a~ Avermectin B~1a~ degraded (30--40% AR) forming mainly its monosaccharide (10--20% AR) (EFSA, [2008](#efs25254-bib-0002){ref-type="ref"})Baking, brewing and boiling (60 min, 100°C, pH 5)YesSterilisation (20 min, 120°C, pH 6)Yes[^10]

![](EFS2-16-e05254-g002.jpg "image")

#### B.1.1.2.. Stability of residues in plants {#efs25254-sec-0030}

Plant products (available studies)CategoryCommodityT (°C)Stability (months/years)High water contentNot specifiedDeep freeze3 yearsHigh oil contentNot specifiedDeep freeze2 yearsDry/High starch------High acid contentNot specifiedDeep freeze14 monthsOrangesDeep freeze12 monthsComments: Orange peel and pulp (Spain, [2018](#efs25254-bib-0028){ref-type="ref"}) Reference: EFSA ([2008](#efs25254-bib-0002){ref-type="ref"})

### B.1.2.. Magnitude of residues in plants {#efs25254-sec-0031}

#### B.1.2.1.. Summary of residues data from the supervised residue trials {#efs25254-sec-0032}

CommodityRegion/indoor[a](#efs25254-note-1025){ref-type="fn"}Residue levels observed in the supervised residue trials (mg/kg)Comments/source[b](#efs25254-note-1026){ref-type="fn"}Calculated MRL (mg/kg)HR[c](#efs25254-note-1027){ref-type="fn"} (mg/kg)STMR[d](#efs25254-note-1028){ref-type="fn"} (mg/kg)CF[e](#efs25254-note-1029){ref-type="fn"}Citrus fruitsSEU16 × \< 0.01; 0.021; 0.029 Pulp: 18 × \< 0.01Residue trials on oranges (8) and mandarins (8) compliant with the GAP (within 25% accepted deviation range, except in two last (ca. + 28%) and three‐first (ca. + 32%) single applications) Pulp: \< LOD, except in one sample (\< LOQ) MRL~OECD~: 0.032 (unrounded) **Extrapolation to whole group of citrus fruits0.04**0.0290.01N/A[^11][^12][^13][^14][^15][^16]

#### B.1.2.2.. Residues in succeeding crops {#efs25254-sec-0033}

![](EFS2-16-e05254-g003.jpg "image")

#### B.1.2.3.. Processing factors {#efs25254-sec-0034}

Processed commodityNumber of valid studies[a](#efs25254-note-1030){ref-type="fn"}Processing factor (PF)CF~P~ [b](#efs25254-note-1031){ref-type="fn"}Comment/sourceIndividual valuesMedian PFCitrus, peeled2\< 0.14; \< 0.19\< 0.17N/ATentative only[^17][^18]

B.2.. Residues in livestock {#efs25254-sec-0035}
---------------------------

Relevant groups (subgroups)Dietary burden expressed inMost critical subgroup[a](#efs25254-note-1033){ref-type="fn"}Most critical commodityTrigger exceeded (Y/N)mg/kg bw per daymg/kg DMMedianMaximumMedianMaximumCattle (all)0.00100.00110.02500.0295Dairy cattleCitrus, dried pulpNoCattle (dairy only)0.00100.00110.02500.0295Dairy cattleCitrus, dried pulpNoSheep (all)0.00050.00060.01300.0175LambApple, pomaceNoSheep (ewe only)0.00040.00060.01300.0175Ram/EweApple, pomaceNoSwine (all)0.00050.00070.02150.0290Swine (breeding)Citrus, dried pulpNoPoultry (all)0.00010.00040.00200.0050TurkeyPotato cullsNoPoultry (layer only)0.00010.00020.00130.0028Poultry layerPotato cullsNoFishN/A[^19][^20]

### B.2.1.. Nature of residues and methods of analysis in livestock {#efs25254-sec-0036}

#### B.2.1.1.. Metabolism studies, methods of analysis and residue definitions in livestock {#efs25254-sec-0037}

Not required.

#### B.2.1.2.. Stability of residues in livestock {#efs25254-sec-0038}

Not required.

### B.2.2.. Magnitude of residues in livestock {#efs25254-sec-0039}

Not required.

B.3.. Consumer risk assessment {#efs25254-sec-0040}
------------------------------

![](EFS2-16-e05254-g004.jpg "image")

B.4.. Recommended MRLs {#efs25254-sec-0041}
----------------------

Code[a](#efs25254-note-1035){ref-type="fn"}CommodityExisting EU MRL (mg/kg)Proposed EU MRL (mg/kg)Comment/justification**Enforcement residue definition:** Abamectin (sum of avermectin B~1a~, avermectin B~1b~ and delta‐8,9‐isomer of avermectin B~1a~, expressed as avermectin B~1a~)0110000Citrus fruits0.0150.04SEU use supported by extrapolation from residue data on oranges and mandarins. Risk for consumers unlikely[^21][^22]

Appendix C -- Pesticide Residue Intake Model (PRIMo) {#efs25254-sec-1004}
====================================================

 {#efs25254-sec-0042}

![](EFS2-16-e05254-g001){#efs25254-fig-0001}

Appendix D -- Input values for the exposure calculations {#efs25254-sec-1005}
========================================================

D.1.. Livestock dietary burden calculations {#efs25254-sec-0043}
-------------------------------------------

Feed commodityMedian dietary burdenMaximum dietary burdenInput value (mg/kg)CommentInput value (mg/kg)Comment**Risk assessment residue definition** Sum of avermectin B~1a~, avermectin B~1b~ and delta‐8,9‐isomer of avermectin B~1a~, expressed as avermectin B~1a~Apple pomace, wet0.040STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"}) × PF[a](#efs25254-note-1037){ref-type="fn"}0.040STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"}) × PF[a](#efs25254-note-1037){ref-type="fn"}Citrus, dried pulp0.100STMR × PF[a](#efs25254-note-1037){ref-type="fn"}----Potato, culls0.002STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"}) × PF[a](#efs25254-note-1037){ref-type="fn"}0.005HR × PF[a](#efs25254-note-1037){ref-type="fn"} (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Potato, process waste0.002STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"}) × PF[a](#efs25254-note-1037){ref-type="fn"}----Potato, dried pulp0.002STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"}) × PF[a](#efs25254-note-1037){ref-type="fn"}----[^23][^24]

D.2.. Consumer risk assessment {#efs25254-sec-0044}
------------------------------

CommodityChronic risk assessmentAcute risk assessmentInput value (mg/kg)CommentInput value (mg/kg)Comment**Risk assessment residue definition**: Sum of avermectin B~1a~, avermectin B~1b~ and delta‐8,9 isomer of avermectin B~1a~, expressed as avermectin B~1a~Citrus fruits0.010STMR‐Peeled (LOQ)0.010HR‐Peeled (LOQ)Tree nuts0.013STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Acute risk assessment performed only for the crops under assessment.Pome fruits0.008STMR (EFSA, [2015](#efs25254-bib-0005){ref-type="ref"})Apricots0.009STMR (EFSA, [2010](#efs25254-bib-0003){ref-type="ref"})Peaches0.009STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Plums0.006STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Table grapes0.006STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Wine grapes0.006STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Strawberries0.030STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Blackberries0.023STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Raspberries0.023STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Currants (red, black, white)0.006STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Gooseberries0.006STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Bananas0.006STMR‐Peeled (EFSA, [2017](#efs25254-bib-0007){ref-type="ref"})Papayas0.008STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Potatoes0.002STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Radishes0.004STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Garlic, Onions, Shallots0.010STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Spring onions0.006STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Tomatoes0.031STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Peppers0.012STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Aubergines (egg plants)0.031STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Cucurbits, edible peel0.007STMR (EFSA, [2015](#efs25254-bib-0005){ref-type="ref"})Cucurbits, inedible peel0.006STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Chinese cabbages0.009STMR (EFSA, [2015](#efs25254-bib-0005){ref-type="ref"})Lamb\'s lettuces0.055STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Lettuces0.010STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Scarole (broad‐leaf endive)0.020STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Rocket, Rucola0.005STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Baby leaf crops (including brassica species)0.055STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Witloofs0.006STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Herbs, except celery leaves0.127STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Celery leaves0.010STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Beans (with pods)0.007STMR (EFSA, [2015](#efs25254-bib-0005){ref-type="ref"})Peas (with pods)0.007STMR (EFSA, [2015](#efs25254-bib-0005){ref-type="ref"})Celeries0.015STMR (EFSA, [2015](#efs25254-bib-0005){ref-type="ref"})Leeks0.006STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Hops (dried)0.016STMR (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Risk assessment residue definition: Sum of avermectin B~1a~ and B~1b~, expressed as avermectin B~1a~Bovine, Meat0.013[a](#efs25254-note-1039){ref-type="fn"}V‐MRL × CF (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Bovine, Fat0.013V‐MRL × CF (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Bovine, Liver0.025V‐MRL × CF (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Bovine, Kidney0.010V‐ LOQ (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Bovine, Edible offal0.025V‐MRL × CF (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Sheep, Meat0.033[a](#efs25254-note-1039){ref-type="fn"}V‐MRL × CF (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Sheep, Fat0.063V‐MRL × CF (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})Sheep; Liver0.031V‐MRL × CF (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"}Sheep; Kidney0.025V‐MRL × CF (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"}Sheep, Edible offal0.063V‐MRL × CF (EFSA, [2014](#efs25254-bib-0004){ref-type="ref"})[^25][^26][^27]

Appendix E -- Used compound codes {#efs25254-sec-1006}
=================================

 {#efs25254-sec-0045}

Code/trivial nameChemical name/SMILES notation[a](#efs25254-note-1042){ref-type="fn"}Structural formula[a](#efs25254-note-1042){ref-type="fn"}Avermectin B~1a~(2a*E*,4*E*,8*E*)‐(5′*S*,6*S*,6′*R*,7*S*,11*R*,13*S*,15*S*,17a*R*,20*R*,20a*R*,20b*S*)‐6′‐\[(*S*)‐*sec*‐butyl\]‐5′,6,6′,7,10,11,14,15,17a,20,20a,20b‐dodecahydro‐20,20b‐dihydroxy‐5′,6,8,19‐tetramethyl‐17‐oxospiro\[11,15‐methano‐2*H*,13*H*,17*H*‐furo\[4,3,2‐*pq*\]\[2,6\]benzodioxacyclooctadecin‐13,2′‐\[2*H*\]pyran\]‐7‐yl 2,6‐dideoxy‐4‐*O*‐(2,6‐dideoxy‐3‐*O*‐methyl‐α‐[l]{.smallcaps}‐arabino‐hexopyranosyl)‐3‐*O*‐methyl‐α‐[l]{.smallcaps}‐arabino‐hexopyranoside CO\[C\@H\]1C\[C@\@H\](O\[C@\@H\](C)\[C@\@H\]1O)O\[C@\@H\]2\[C@\@H\](OC)C\[C@\@H\](O\[C\@H\]2C)O\[C@\@H\]3C(C)=CC\[C@\@H\]6C\[C\@H\](OC(=O)\[C@\@H\]4C=C(C)\[C@\@H\](O)\[C\@H\]5OCC(=CC=C\[C@\@H\]3C)\[C@@\]45O)C\[C@@\]7(O6)C=C\[C\@H\](C)\[C\@H\](O7)\[C@\@H\](C)CC![](EFS2-16-e05254-g005.jpg "image")Avermectin B~1b~(2a*E*,4*E*,8*E*)‐(5′*S*,6*S*,6′*R*,7*S*,11*R*,13*S*,15*S*,17a*R*,20*R*,20a*R*,20b*S*)‐5′,6,6′,7,10,11,14,15,17a,20,20a,20b‐dodecahydro‐20,20b‐dihydroxy‐6′‐isopropyl‐5′,6,8,19‐tetramethyl‐17‐oxospiro\[11,15‐methano‐2*H*,13*H*,17*H*‐furo\[4,3,2‐*pq*\]\[2,6\]benzodioxacyclooctadecin‐13,2′‐\[2*H*\]pyran\]‐7‐yl 2,6‐dideoxy‐4‐*O*‐(2,6‐dideoxy‐3‐*O*‐methyl‐α‐[l]{.smallcaps}‐arabino‐hexopyranosyl)‐3‐*O*‐methyl‐α‐[l]{.smallcaps}‐arabino‐hexopyranoside CO\[C\@H\]1C\[C@\@H\](O\[C@\@H\](C)\[C@\@H\]1O)O\[C@\@H\]2\[C@\@H\](OC)C\[C@\@H\](O\[C\@H\]2C)O\[C@\@H\]3C(C)=CC\[C@\@H\]6C\[C\@H\](OC(=O)\[C@\@H\]4C=C(C)\[C@\@H\](O)\[C\@H\]5OCC(=CC=C\[C@\@H\]3C)\[C@@\]45O)C\[C@@\]7(O6)C=C\[C\@H\](C)\[C\@H\](O7)C(C)C![](EFS2-16-e05254-g006.jpg "image")δ‐8,9‐isomer of avermectin B~1a~ or \[8,9‐*Z*\]‐isomer of avermectin B~1a~ (NOA 427011)(2a*Z*,4*E*,8*E*)‐(5′*S*,6*S*,6′*R*,7*S*,11*R*,13*S*,15*S*,17a*R*,20*R*,20a*R*,20b*S*)‐6′‐\[(*S*)‐*sec*‐butyl\]‐5′,6,6′,7,10,11,14,15,17a,20,20a,20b‐dodecahydro‐20,20b‐dihydroxy‐5′,6,8,19‐tetramethyl‐17‐oxospiro\[11,15‐methano‐2*H*,13*H*,17*H*‐furo\[4,3,2‐*pq*\]\[2,6\]benzodioxacyclooctadecin‐13,2′‐\[2*H*\]pyran\]‐7‐yl 2,6‐dideoxy‐4‐*O*‐(2,6‐dideoxy‐3‐*O*‐methyl‐α‐[l]{.smallcaps}‐arabino‐hexopyranosyl)‐3‐*O*‐methyl‐α‐[l]{.smallcaps}‐*arabino*‐hexopyranoside CO\[C\@H\]1C\[C@\@H\](O\[C@\@H\](C)\[C@\@H\]1O)O\[C@\@H\]2\[C@\@H\](OC)C\[C@\@H\](O\[C\@H\]2C)O\[C@\@H\]3C(C)=CC\[C@\@H\]6C\[C\@H\](OC(=O)\[C@\@H\]4C=C(C)\[C@\@H\](O)\[C\@H\]5OCC(=CC=C\[C@\@H\]3C)\[C@@\]45O)C\[C@@\]7(O6)C=C\[C\@H\](C)\[C\@H\](O7)\[C@\@H\](C)CC![](EFS2-16-e05254-g007.jpg "image")[^28][^29]

Regulation (EC) No 396/2005 of the Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC. OJ L 70, 16.3.2005, p. 1--16.

Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market. OJ L 230, 19.8.1991, p. 1--32.

Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. OJ L 309, 24.11.2009, p. 1--50.

Commission Directive 2008/107/EC of 25 November 2008 amending Council Directive 91/414/EEC to include abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim as active substances. OJ L 316, 26.11.2008, p. 4--11.

Commission Implementing Regulation (EU) 2017/438 of 13 March 2017 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance abamectin. OJ L 67, 14.3.2017, p. 67--69.

Commission Regulation (EU) 2015/2075 of 18 November 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for abamectin, desmedipham, dichlorprop‐P, haloxyfop‐P, oryzalin and phenmedipham in or on certain products. OJ L 302, 19.11.2015, p. 15--50.

Commission Regulation (EU) 2016/1003 of 17 June 2016 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for abamectin, acequinocyl, acetamiprid, benzovindiflupyr, bromoxynil, fludioxonil, fluopicolide, fosetyl, mepiquat, proquinazid, propamocarb, prohexadione and tebuconazole in or on certain products. OJ L 167, 24.6.2016, p. 46--103.

Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1--72.

Commission Regulation (EU) No 544/2011 of 10 June 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the data requirements for active substances. OJ L 155, 11.6.2011, p. 1--66.

Commission Regulation (EU) No 546/2011 of 10 June 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards uniform principles for evaluation and authorisation of plant protection products. OJ L 155, 11.6.2011, p. 127--175.

[^1]: MRL: maximum residue level; SEU: southern Europe.

[^2]: ^a^ Commodity code number according to Annex I of Regulation (EC) No 396/2005.

[^3]: ^F^Fat soluble.

[^4]: ^R^Code 1000000 except 1040000: avermectin B~1a~.

[^5]: NEU: northern European Union; SEU: southern European Union; MS: Member State; GAP: Good Agricultural Practice; MRL: maximum residue level; EC: emulsifiable concentrate.

[^6]: Outdoor or field use (F), greenhouse application (G) or indoor application (I).

[^7]: CropLife International Technical Monograph no 2, 6th Edition. Revised May 2008. Catalogue of pesticide formulation types and international coding system.

[^8]: Growth stage range from first to last treatment (BBCH Monograph, Growth Stages of Plants, 1997, Blackwell, ISBN 3‐8263‐3152‐4), including, where relevant, information on season at time of application.

[^9]: PHI: minimum preharvest interval.

[^10]: F: field application; G: glasshouse application; DAT: days after treatment; DALA: days after last application; PBI: plant‐back interval.

[^11]: MRL: maximum residue level; GAP: Good Agricultural Practice; LOD: limit of detection; LOQ: limit of quantification; OECD: Organisation for Economic Co‐operation and Development.

[^12]: NEU: Outdoor trials conducted in northern Europe, SEU: Outdoor trials conducted in southern Europe, Indoor: indoor EU trials or Country code: if non‐EU trials.

[^13]: Individual residue values were reported as sum of avermectin B~1a~, avermectin B~1b~ and delta‐8,9 isomer of avermectin B~1a~, expressed as avermectin B~1a~ (combined LOQ 0.01 mg/kg).

[^14]: Highest residue refers to the whole commodity and not to the edible portion of the fruit (pulp).

[^15]: Supervised trials median residue refers to the whole commodity and not to the edible portion (pulp).

[^16]: Conversion factor to recalculate residues according to the residue definition for monitoring to the residue definition for risk assessment. N/A not applicable.

[^17]: Studies with residues in the RAC at or close to the LOQ were disregarded (unless concentration may occur).

[^18]: Conversion factor for risk assessment in the processed commodity; median of the individual conversion factors for each processing residue trial. For the residues of abamectin in the pulp, the limit of detection of 0.004 mg/kg was used in the calculation.

[^19]: bw: body weight; DM: dry matter.

[^20]: When one group of livestock includes several subgroups (e.g. poultry 'all' including broiler, layer and turkey), the result of the most critical subgroup is identified from the maximum dietary burdens expressed as 'mg/kg bw per day'.

[^21]: MRL: maximum residue level; SEU: southern Europe.

[^22]: Commodity code number according to Annex I of Regulation (EC) No 396/2005.

[^23]: STMR: supervised trials median residue; HR: highest residue; PF: processing factor.

[^24]: For fruit by products, in the absence of processing factors supported by data, default processing factors (PF) of 5 (apple wet pomace) and 10 (citrus dried pulp) were included in the calculation. For potato processed waste and dried pulp a PF of 1 was applied. Assuming a zero‐residue in potatoes, concentration of residues is not expected in these feed items.

[^25]: STMR: supervised trials median residue; HR: highest residue; LOQ: limit of quantification; MRL: maximum residue level; CF: conversion factor for enforcement to risk assessment residue definition.

[^26]: Consumption figures in the EFSA PRIMo are expressed as meat. Since the active substance is fat‐soluble, STMR and HR residue values were calculated considering a 80% muscle and 20% fat content for mammal meat (FAO, [2016](#efs25254-bib-0023){ref-type="ref"}).

[^27]: MRL resulting from the veterinary use of abamectin (V‐MRL) are derived for avermectin B~1a~. A conversion factor (CF) of 1.25 was used to take into account the consumer exposure to avermectin B~1~.

[^28]: SMILES: simplified molecular‐input line‐entry system.

[^29]: (ACD/ChemSketch, Advanced Chemistry Development, Inc., ACD/Labs Release: 12.00 Product version: 12.00 (Build 29305, 25 November 2008).
